1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Long-acting Injectable Medications Market Size 2016-2026

2.1.2 Long-acting Injectable Medications Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Long-acting Injectable Medications Segment by Type

2.2.1 First-generation

2.2.2 First-generation

2.3 Long-acting Injectable Medications Market Size by Type

2.3.1 Global Long-acting Injectable Medications Market Size CAGR by Type

2.3.2 Global Long-acting Injectable Medications Market Size Market Share by Type (2016-2021)

2.4 Long-acting Injectable Medications Segment by Application

2.4.1 Schizophrenia

2.4.2 Contraception

2.4.3 HIV

2.4.4 Others

2.5 Long-acting Injectable Medications Market Size by Application

2.5.1 Global Long-acting Injectable Medications Market Size CAGR by Application

2.5.2 Global Long-acting Injectable Medications Market Size Market Share by Application (2016-2021)

3 Long-acting Injectable Medications Market Size by Players

3.1 Long-acting Injectable Medications Market Size Market Share by Players

3.1.1 Global Long-acting Injectable Medications Revenue by Players (2019-2021E)

3.1.2 Global Long-acting Injectable Medications Revenue Market Share by Players (2019-2021E)

3.2 Global Long-acting Injectable Medications Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Long-acting Injectable Medications by Regions

4.1 Long-acting Injectable Medications Market Size by Regions (2016-2021)

4.2 Americas Long-acting Injectable Medications Market Size Growth (2016-2021)

4.3 APAC Long-acting Injectable Medications Market Size Growth (2016-2021)

4.4 Europe Long-acting Injectable Medications Market Size Growth (2016-2021)

4.5 Middle East & Africa Long-acting Injectable Medications Market Size Growth (2016-2021)

5 Americas

5.1 Americas Long-acting Injectable Medications Market Size by Country (2016-2021)

5.2 Americas Long-acting Injectable Medications Market Size by Type (2016-2021)

5.3 Americas Long-acting Injectable Medications Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Long-acting Injectable Medications Market Size by Region (2016-2021)

6.2 APAC Long-acting Injectable Medications Market Size by Type (2016-2021)

6.3 APAC Long-acting Injectable Medications Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Long-acting Injectable Medications by Country (2016-2021)

7.2 Europe Long-acting Injectable Medications Market Size by Type (2016-2021)

7.3 Europe Long-acting Injectable Medications Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Long-acting Injectable Medications by Region (2016-2021)

8.2 Middle East & Africa Long-acting Injectable Medications Market Size by Type (2016-2021)

8.3 Middle East & Africa Long-acting Injectable Medications Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Long-acting Injectable Medications Market Forecast

10.1 Global Long-acting Injectable Medications Forecast by Regions (2021-2026)

10.1.1 Global Long-acting Injectable Medications Forecast by Regions (2021-2026)

10.1.2 Americas Long-acting Injectable Medications Forecast

10.1.3 APAC Long-acting Injectable Medications Forecast

10.1.4 Europe Long-acting Injectable Medications Forecast

10.1.5 Middle East & Africa Long-acting Injectable Medications Forecast

10.2 Americas Long-acting Injectable Medications Forecast by Countries (2021-2026)

10.2.1 United States Long-acting Injectable Medications Market Forecast

10.2.2 Canada Long-acting Injectable Medications Market Forecast

10.2.3 Mexico Long-acting Injectable Medications Market Forecast

10.2.4 Brazil Long-acting Injectable Medications Market Forecast

10.3 APAC Long-acting Injectable Medications Forecast by Region (2021-2026)

10.3.1 China Long-acting Injectable Medications Market Forecast

10.3.2 Japan Long-acting Injectable Medications Market Forecast

10.3.3 Korea Long-acting Injectable Medications Market Forecast

10.3.4 Southeast Asia Long-acting Injectable Medications Market Forecast

10.3.5 India Long-acting Injectable Medications Market Forecast

10.3.6 Australia Long-acting Injectable Medications Market Forecast

10.4 Europe Long-acting Injectable Medications Forecast by Country (2021-2026)

10.4.1 Germany Long-acting Injectable Medications Market Forecast

10.4.2 France Long-acting Injectable Medications Market Forecast

10.4.3 UK Long-acting Injectable Medications Market Forecast

10.4.4 Italy Long-acting Injectable Medications Market Forecast

10.4.5 Russia Long-acting Injectable Medications Market Forecast

10.5 Middle East & Africa Long-acting Injectable Medications Forecast by Region (2021-2026)

10.5.1 Egypt Long-acting Injectable Medications Market Forecast

10.5.2 South Africa Long-acting Injectable Medications Market Forecast

10.5.3 Israel Long-acting Injectable Medications Market Forecast

10.5.4 Turkey Long-acting Injectable Medications Market Forecast

10.5.5 GCC Countries Long-acting Injectable Medications Market Forecast

10.6 Global Long-acting Injectable Medications Forecast by Type (2021-2026)

10.8 Global Long-acting Injectable Medications Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Eli Lilly

11.1.1 Eli Lilly Company Information

11.1.2 Eli Lilly Long-acting Injectable Medications Product Offered

11.1.3 Eli Lilly Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Eli Lilly Main Business Overview

11.1.5 Eli Lilly Latest Developments

11.2 Alkermes

11.2.1 Alkermes Company Information

11.2.2 Alkermes Long-acting Injectable Medications Product Offered

11.2.3 Alkermes Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Alkermes Main Business Overview

11.2.5 Alkermes Latest Developments

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Information

11.3.2 Johnson & Johnson Long-acting Injectable Medications Product Offered

11.3.3 Johnson & Johnson Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Johnson & Johnson Main Business Overview

11.3.5 Johnson & Johnson Latest Developments

11.4 Zogenix

11.4.1 Zogenix Company Information

11.4.2 Zogenix Long-acting Injectable Medications Product Offered

11.4.3 Zogenix Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Zogenix Main Business Overview

11.4.5 Zogenix Latest Developments

11.5 DURECT

11.5.1 DURECT Company Information

11.5.2 DURECT Long-acting Injectable Medications Product Offered

11.5.3 DURECT Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 DURECT Main Business Overview

11.5.5 DURECT Latest Developments

11.6 Mapi Pharma

11.6.1 Mapi Pharma Company Information

11.6.2 Mapi Pharma Long-acting Injectable Medications Product Offered

11.6.3 Mapi Pharma Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Mapi Pharma Main Business Overview

11.6.5 Mapi Pharma Latest Developments

11.7 GSK

11.7.1 GSK Company Information

11.7.2 GSK Long-acting Injectable Medications Product Offered

11.7.3 GSK Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 GSK Main Business Overview

11.7.5 GSK Latest Developments

11.8 MedinCell

11.8.1 MedinCell Company Information

11.8.2 MedinCell Long-acting Injectable Medications Product Offered

11.8.3 MedinCell Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 MedinCell Main Business Overview

11.8.5 MedinCell Latest Developments

11.9 Oakwood Labs

11.9.1 Oakwood Labs Company Information

11.9.2 Oakwood Labs Long-acting Injectable Medications Product Offered

11.9.3 Oakwood Labs Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Oakwood Labs Main Business Overview

11.9.5 Oakwood Labs Latest Developments

11.10 Nanomi

11.10.1 Nanomi Company Information

11.10.2 Nanomi Long-acting Injectable Medications Product Offered

11.10.3 Nanomi Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Nanomi Main Business Overview

11.10.5 Nanomi Latest Developments

11. Pharmathen

11.11.1 Pharmathen Company Information

11.11.2 Pharmathen Long-acting Injectable Medications Product Offered

11.11.3 Pharmathen Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Pharmathen Main Business Overview

11.11.5 Pharmathen Latest Developments

11.12 Kashiv BioSciences

11.12.1 Kashiv BioSciences Company Information

11.12.2 Kashiv BioSciences Long-acting Injectable Medications Product Offered

11.12.3 Kashiv BioSciences Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Kashiv BioSciences Main Business Overview

11.12.5 Kashiv BioSciences Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Long-acting Injectable Medications Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of First-generation

Table 3. Major Players of Second-generation

Table 4. Long-acting Injectable Medications Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 5. Global Long-acting Injectable Medications Market Size by Type (2016-2021) & ($ Millions)

Table 6. Global Long-acting Injectable Medications Market Size Market Share by Type (2016-2021)

Table 7. Long-acting Injectable Medications Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 8. Global Long-acting Injectable Medications Market Size by Application (2016-2021) & ($ Millions)

Table 9. Global Long-acting Injectable Medications Market Size Market Share by Application (2016-2021)

Table 10. Global Long-acting Injectable Medications Revenue by Players (2019-2021E) & ($ Millions)

Table 11. Global Long-acting Injectable Medications Revenue Market Share by Players (2019-2021E)

Table 12. Long-acting Injectable Medications Key Players Head office and Products Offered

Table 13. Long-acting Injectable Medications Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Long-acting Injectable Medications Market Size by Regions 2016-2021 & ($ Millions)

Table 17. Global Long-acting Injectable Medications Market Size Market Share by Regions 2016-2021

Table 18. Americas Long-acting Injectable Medications Market Size by Country (2016-2021) & ($ Millions)

Table 19. Americas Long-acting Injectable Medications Market Size Market Share by Country (2016-2021)

Table 20. Americas Long-acting Injectable Medications Market Size by Type (2016-2021) & ($ Millions)

Table 21. Americas Long-acting Injectable Medications Market Size Market Share by Type (2016-2021)

Table 22. Americas Long-acting Injectable Medications Market Size by Application (2016-2021) & ($ Millions)

Table 23. Americas Long-acting Injectable Medications Market Size Market Share by Application (2016-2021)

Table 24. APAC Long-acting Injectable Medications Market Size by Region (2016-2021) & ($ Millions)

Table 25. APAC Long-acting Injectable Medications Market Size Market Share by Region (2016-2021)

Table 26. APAC Long-acting Injectable Medications Market Size by Type (2016-2021) & ($ Millions)

Table 27. APAC Long-acting Injectable Medications Market Size Market Share by Type (2016-2021)

Table 28. APAC Long-acting Injectable Medications Market Size by Application (2016-2021) & ($ Millions)

Table 29. APAC Long-acting Injectable Medications Market Size Market Share by Application (2016-2021)

Table 30. Europe Long-acting Injectable Medications Market Size by Country (2016-2021) & ($ Millions)

Table 31. Europe Long-acting Injectable Medications Market Size Market Share by Country (2016-2021)

Table 32. Europe Long-acting Injectable Medications Market Size by Type (2016-2021) & ($ Millions)

Table 33. Europe Long-acting Injectable Medications Market Size Market Share by Type (2016-2021)

Table 34. Europe Long-acting Injectable Medications Market Size by Application (2016-2021) & ($ Millions)

Table 35. Europe Long-acting Injectable Medications Market Size Market Share by Application (2016-2021)

Table 36. Middle East & Africa Long-acting Injectable Medications Market Size by Region (2016-2021) & ($ Millions)

Table 37. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Region (2016-2021)

Table 38. Middle East & Africa Long-acting Injectable Medications Market Size by Type (2016-2021) & ($ Millions)

Table 39. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Type (2016-2021)

Table 40. Middle East & Africa Long-acting Injectable Medications Market Size by Application (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Application (2016-2021)

Table 42. Key and Potential Regions of Long-acting Injectable Medications

Table 43. Key Application and Potential Industries of Long-acting Injectable Medications

Table 44. Key Challenges of Long-acting Injectable Medications

Table 45. Key Trends of Long-acting Injectable Medications

Table 46. Global Long-acting Injectable Medications Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 47. Global Long-acting Injectable Medications Market Size Market Share Forecast by Regions (2021-2026)

Table 48. Global Long-acting Injectable Medications Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 49. Global Long-acting Injectable Medications Market Size Market Share Forecast by Type (2021-2026)

Table 50. Global Long-acting Injectable Medications Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 51. Global Long-acting Injectable Medications Market Size Market Share Forecast by Application (2021-2026)

Table 52. Eli Lilly Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 53. Eli Lilly Long-acting Injectable Medications Product Offered

Table 54. Eli Lilly Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 55. Eli Lilly Main Business

Table 56. Eli Lilly Latest Developments

Table 57. Alkermes Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 58. Alkermes Long-acting Injectable Medications Product Offered

Table 59. Alkermes Main Business

Table 60. Alkermes Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 61. Alkermes Latest Developments

Table 62. Johnson & Johnson Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 63. Johnson & Johnson Long-acting Injectable Medications Product Offered

Table 64. Johnson & Johnson Main Business

Table 65. Johnson & Johnson Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 66. Johnson & Johnson Latest Developments

Table 67. Zogenix Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 68. Zogenix Long-acting Injectable Medications Product Offered

Table 69. Zogenix Main Business

Table 70. Zogenix Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 71. Zogenix Latest Developments

Table 72. DURECT Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 73. DURECT Long-acting Injectable Medications Product Offered

Table 74. DURECT Main Business

Table 75. DURECT Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 76. DURECT Latest Developments

Table 77. Mapi Pharma Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 78. Mapi Pharma Long-acting Injectable Medications Product Offered

Table 79. Mapi Pharma Main Business

Table 80. Mapi Pharma Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 81. Mapi Pharma Latest Developments

Table 82. GSK Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 83. GSK Long-acting Injectable Medications Product Offered

Table 84. GSK Main Business

Table 85. GSK Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 86. GSK Latest Developments

Table 87. MedinCell Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 88. MedinCell Long-acting Injectable Medications Product Offered

Table 89. MedinCell Main Business

Table 90. MedinCell Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 91. MedinCell Latest Developments

Table 92. Oakwood Labs Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 93. Oakwood Labs Long-acting Injectable Medications Product Offered

Table 94. Oakwood Labs Main Business

Table 95. Oakwood Labs Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 96. Oakwood Labs Latest Developments

Table 97. Nanomi Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 98. Nanomi Long-acting Injectable Medications Product Offered

Table 99. Nanomi Main Business

Table 100. Nanomi Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 101. Nanomi Latest Developments

Table 102. Pharmathen Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 103. Pharmathen Long-acting Injectable Medications Product Offered

Table 104. Pharmathen Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 105. Pharmathen Main Business

Table 106. Pharmathen Latest Developments

Table 107. Kashiv BioSciences Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 108. Kashiv BioSciences Long-acting Injectable Medications Product Offered

Table 109. Kashiv BioSciences Main Business

Table 110. Kashiv BioSciences Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 111. Kashiv BioSciences Latest Developments

List of Figures

Figure 1. Long-acting Injectable Medications Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Long-acting Injectable Medications Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Long-acting Injectable Medications Market Size Market Share by Type in 2020

Figure 7. Long-acting Injectable Medications in Schizophrenia

Figure 8. Global Long-acting Injectable Medications Market: Schizophrenia (2016-2021) & ($ Millions)

Figure 9. Long-acting Injectable Medications in Contraception

Figure 10. Global Long-acting Injectable Medications Market: Contraception (2016-2021) & ($ Millions)

Figure 11. Long-acting Injectable Medications in HIV

Figure 12. Global Long-acting Injectable Medications Market: HIV (2016-2021) & ($ Millions)

Figure 13. Long-acting Injectable Medications in Others

Figure 14. Global Long-acting Injectable Medications Market: Others (2016-2021) & ($ Millions)

Figure 15. Global Long-acting Injectable Medications Market Size Market Share by Application in 2020

Figure 16. Global Long-acting Injectable Medications Revenue Market Share by Player in 2020

Figure 17. Global Long-acting Injectable Medications Market Size Market Share by Regions (2016-2021)

Figure 18. Americas Long-acting Injectable Medications Market Size 2016-2021 ($ Millions)

Figure 19. APAC Long-acting Injectable Medications Market Size 2016-2021 ($ Millions)

Figure 20. Europe Long-acting Injectable Medications Market Size 2016-2021 ($ Millions)

Figure 21. Middle East & Africa Long-acting Injectable Medications Market Size 2016-2021 ($ Millions)

Figure 22. Americas Long-acting Injectable Medications Market Size Market Share by Country in 2020

Figure 23. Americas Long-acting Injectable Medications Market Size Market Share by Type in 2020

Figure 24. Americas Long-acting Injectable Medications Market Size Market Share by Application in 2020

Figure 25. United States Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 26. Canada Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 27. Mexico Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 28. APAC Long-acting Injectable Medications Market Size Market Share by Regions in 2020

Figure 29. APAC Long-acting Injectable Medications Market Size Market Share by Type in 2020

Figure 30. APAC Long-acting Injectable Medications Market Size Market Share by Application in 2020

Figure 31. China Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 32. Japan Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 33. Korea Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 34. Southeast Asia Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 35. India Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 36. Australia Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 37. Europe Long-acting Injectable Medications Market Size Market Share by Country in 2020

Figure 38. Europe Long-acting Injectable Medications Market Size Market Share by Type in 2020

Figure 39. Europe Long-acting Injectable Medications Market Size Market Share by Application in 2020

Figure 40. Germany Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 41. France Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 42. UK Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 43. Italy Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 44. Russia Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 45. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Region in 2020

Figure 46. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Type in 2020

Figure 47. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Application in 2020

Figure 48. Egypt Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 49. South Africa Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 50. Israel Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 51. Turkey Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 52. GCC Country Long-acting Injectable Medications Market Size Growth 2016-2021 ($ Millions)

Figure 53. Americas Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 54. APAC Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 55. Europe Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 56. Middle East & Africa Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 57. United States Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 58. Canada Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 59. Mexico Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 60. Brazil Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 61. China Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 62. Japan Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 63. Korea Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 64. Southeast Asia Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 65. India Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 66. Australia Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 67. Germany Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 68. France Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 69. UK Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 70. Italy Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 71. Russia Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 72. Spain Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 73. Egypt Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 74. South Africa Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 75. Israel Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 76. Turkey Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)

Figure 77. GCC Country Long-acting Injectable Medications Market Size 2021-2026 ($ Millions)